The US Food and Drug Administration in recent years has taken to holding regulatory meetings with device makers rather than immediately sending warning letters. Preparing for these meetings is critical and will increase the chances of a positive outcome, a longtime industry expert advises.
“Regulatory meetings can be a win-win for both parties, for FDA as well as for industry” – as long as...